TLRYTilray Brands, Inc.
$3.54-79% 1Y
$3.54
$3.5452 weeks$21.00
Latest close: a new 52-week lowOct 9, 2026what changed →
TLRY in its own filings
TLRY's filing record carries one kind of hard flag, each is shown beside the share of the whole market carrying the same one, because more than half of all companies carry at least one.
247
Events found in the filings · across 770 filings · the record starts in 2018
- Hard flags
- 1
Hard flags
- Most recent filing
- Oct 8, 2026
Most recent filing · Form 10-Q
- Record starts
- Apr 17, 2018
Record starts · the earliest filing Ryufin holds for this name
Details›
- Next results filingsame week as a year ago
- expected around Jan 7, 2027
- Change in certifying accountanthistorical
- 2021-05-21
- Delisting notice / listing-rule failurepast_3y
- 2025-03-25
- Material impairmenthistorical
- 2020-06-01
- SEC comment-letter activity19 occurrences
- 2026-03-18
SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.
What the company said
The company's own words from its current reports to the SEC, newest first
- Oct 8, 2026Tilray Brands Delivers Record Q1 Fiscal 2027 Revenue and Record Q1 Gross Profit, Demonstrating the Power of Its Global Platform, Driven by Double-Digit Year-Over-Year Growth Across International Cannabis, Beverage and Pharmaceutical Distribution.Earnings release · press release
- Sep 14, 2026Between August 31, 2026 and September 8, 2026, Tilray Brands, Inc. (the “Company”) entered into certain private debt-for-equity exchange transactions (the “Exchange Transactions”) with unrelated parties.Unregistered sale of equity · Form 8-K
- Aug 10, 2026On August 4, 2026, Tilray Brands, Inc. (the “Company”) entered into certain private debt-for-equity exchange transactions (the “Exchange Transactions”) with unrelated parties.Unregistered sale of equity · Form 8-K
- Jul 28, 2026Tilray Brands Delivers Record Fiscal 2026 Revenue and Adjusted EBITDA; Demonstrating the Strength of its Diversified Global Platform Across Cannabis, Beverage, Hospitality and Wellness.Earnings release · press release
- Jun 30, 2026Between June 15, 2026 and June 24, 2026, Tilray Brands, Inc. (the “Company”) entered into certain private debt-for-equity exchange transactions (the “Exchange Transactions”) with unrelated parties.Unregistered sale of equity · Form 8-K
- Jun 9, 2026On April 15, 2026, Tilray Brands, Inc. (the “Company”) issued 398,666 shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”), as partial consideration pursuant to that certain share purchase agreement, dated April 15, 2026, by and among the Company, Tilray Holdings, Inc., a wholly-owned …Unregistered sale of equity · Form 8-K
- Apr 21, 2026This current report on Form 8-K is filed for the purpose of filing the attached exhibit in connection with the Registration Statement No. 333-290806.Other event · Form 8-K
- Apr 15, 2026On April 15, 2026 Tilray Brands, Inc. (the “Company” or “Tilray”) entered into an Open Market Sale Agreement SM (the “Sales Agreement”) with Jefferies LLC, TD Securities (USA) LLC and Roth Capital Partners, LLC (each, an “Agent” and together, the “Agents”), pursuant to which the Company may offer and sell shares of …Material agreement entered · Form 8-K
- Apr 15, 2026Between April 1, 2026 and April 8, 2026, Tilray Brands, Inc. (the “Company”) entered into certain private debt-for-equity exchange transactions (the “Exchange Transactions”) with unrelated parties.Unregistered sale of equity · Form 8-K
- Apr 1, 2026Tilray Brands Delivers Record Q3 Fiscal 2026 Results; Net Revenue Increases to $207 Million with 11% Organic Growth and Gross Profit Expands to $55 Million, Increasing 6% Year-Over-Year.Earnings release · press release
- Mar 2, 2026On March 2, 2026, Tilray Brands UK Ltd (“Tilray UK”), a company registered in the United Kingdom and wholly owned and controlled by Tilray Brands, Inc. (the “Company”), entered into a Business and Asset Sale Agreement (the “Purchase Agreement”)Material agreement entered · Form 8-K
- Jan 8, 2026Tilray Brands Delivers Record Q2 Fiscal 2026 Net Revenue of $218 Million, Moves to Net Cash Position and Reaffirms Full-Year Adjusted EBITDA Guidance.Earnings release · press release
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
opening the record…
Drug Manufacturers, Specialty & Generic
Ranks #32 of 41 by RyuScore